Cabaletta Bio is trading 10.1% down at $2.94 amid broad risk-off pressure linked to escalating U.S.-Iran tensions and Brent crude exceeding $100 per barrel.
- Presented positive rese-cel safety and manufacturing updates at the Cantor Fitzgerald healthcare conference.
- No company-specific negative catalyst was identified.
- Major U.S. indices are also lower, reinforcing a global sentiment-driven move.